

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glutamate secretion (GO:0014047) | 5.22517114 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.86256452 |
| 3 | lysine catabolic process (GO:0006554) | 4.45921575 |
| 4 | lysine metabolic process (GO:0006553) | 4.45921575 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.34817742 |
| 6 | carnitine shuttle (GO:0006853) | 4.33517460 |
| 7 | positive regulation of synapse maturation (GO:0090129) | 4.33033705 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 4.21008096 |
| 9 | central nervous system myelination (GO:0022010) | 4.21008096 |
| 10 | cerebellar granule cell differentiation (GO:0021707) | 4.20046262 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 4.18789523 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 4.16930591 |
| 13 | potassium ion homeostasis (GO:0055075) | 4.10357007 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.82274309 |
| 15 | carnitine transport (GO:0015879) | 3.79368239 |
| 16 | amino-acid betaine transport (GO:0015838) | 3.79368239 |
| 17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.77828096 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 3.76465270 |
| 19 | regulation of sequestering of triglyceride (GO:0010889) | 3.75770739 |
| 20 | carnitine transmembrane transport (GO:1902603) | 3.71605373 |
| 21 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.69403479 |
| 22 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.67430952 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.66319394 |
| 24 | aspartate family amino acid catabolic process (GO:0009068) | 3.63211949 |
| 25 | cellular sodium ion homeostasis (GO:0006883) | 3.58387226 |
| 26 | NADH metabolic process (GO:0006734) | 3.54731966 |
| 27 | fatty acid beta-oxidation (GO:0006635) | 3.53871023 |
| 28 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.52532632 |
| 29 | L-amino acid import (GO:0043092) | 3.51325422 |
| 30 | succinate metabolic process (GO:0006105) | 3.49372774 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 3.49301897 |
| 32 | regulation of synapse maturation (GO:0090128) | 3.48660834 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.47308437 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 3.43002114 |
| 35 | regulation of fatty acid oxidation (GO:0046320) | 3.42643182 |
| 36 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.36307195 |
| 37 | quaternary ammonium group transport (GO:0015697) | 3.36291343 |
| 38 | vocalization behavior (GO:0071625) | 3.35654669 |
| 39 | positive regulation of fatty acid oxidation (GO:0046321) | 3.34375633 |
| 40 | sodium ion export (GO:0071436) | 3.33948840 |
| 41 | synaptic vesicle maturation (GO:0016188) | 3.27502572 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26499465 |
| 43 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.26477850 |
| 44 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.24666919 |
| 45 | locomotory exploration behavior (GO:0035641) | 3.23069898 |
| 46 | neuronal ion channel clustering (GO:0045161) | 3.20683465 |
| 47 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.20680679 |
| 48 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.20287974 |
| 49 | fatty acid oxidation (GO:0019395) | 3.17329337 |
| 50 | cell communication by electrical coupling (GO:0010644) | 3.16927832 |
| 51 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.16880169 |
| 52 | valine metabolic process (GO:0006573) | 3.15413463 |
| 53 | regulation of ARF protein signal transduction (GO:0032012) | 3.15295443 |
| 54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.14601227 |
| 55 | neuromuscular process controlling balance (GO:0050885) | 3.14111348 |
| 56 | lipid oxidation (GO:0034440) | 3.13830137 |
| 57 | tricarboxylic acid metabolic process (GO:0072350) | 3.11403417 |
| 58 | potassium ion import (GO:0010107) | 3.11104550 |
| 59 | cellular potassium ion homeostasis (GO:0030007) | 3.11041050 |
| 60 | neurotransmitter transport (GO:0006836) | 3.10743743 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 3.10603840 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.09149057 |
| 63 | neuronal action potential propagation (GO:0019227) | 3.08630525 |
| 64 | acetyl-CoA metabolic process (GO:0006084) | 3.07258860 |
| 65 | amino acid import (GO:0043090) | 3.07213282 |
| 66 | carnitine metabolic process (GO:0009437) | 3.06689978 |
| 67 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.06467314 |
| 68 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.05398397 |
| 69 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.05017635 |
| 70 | drug catabolic process (GO:0042737) | 3.04963752 |
| 71 | regulation of membrane repolarization (GO:0060306) | 3.03825508 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.01812957 |
| 73 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.01032326 |
| 74 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.00535391 |
| 75 | biotin metabolic process (GO:0006768) | 2.99816045 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.98710400 |
| 77 | cardiac muscle contraction (GO:0060048) | 2.98682917 |
| 78 | positive regulation of dendritic spine development (GO:0060999) | 2.98230859 |
| 79 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.97825731 |
| 80 | fatty acid catabolic process (GO:0009062) | 2.97570523 |
| 81 | exploration behavior (GO:0035640) | 2.97103209 |
| 82 | exogenous drug catabolic process (GO:0042738) | 2.96988622 |
| 83 | * respiratory electron transport chain (GO:0022904) | 2.94859507 |
| 84 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.94387408 |
| 85 | axonemal dynein complex assembly (GO:0070286) | 2.93750943 |
| 86 | glycine transport (GO:0015816) | 2.93744779 |
| 87 | regulation of cofactor metabolic process (GO:0051193) | 2.93717418 |
| 88 | regulation of coenzyme metabolic process (GO:0051196) | 2.93717418 |
| 89 | regulation of triglyceride catabolic process (GO:0010896) | 2.91568894 |
| 90 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.90610452 |
| 91 | creatine metabolic process (GO:0006600) | 2.88962455 |
| 92 | relaxation of cardiac muscle (GO:0055119) | 2.88444577 |
| 93 | cellular ketone body metabolic process (GO:0046950) | 2.88220968 |
| 94 | homocysteine metabolic process (GO:0050667) | 2.86257541 |
| 95 | * electron transport chain (GO:0022900) | 2.86093154 |
| 96 | plasma membrane repair (GO:0001778) | 2.83732862 |
| 97 | glutamate metabolic process (GO:0006536) | 2.81938268 |
| 98 | cardiac conduction (GO:0061337) | 2.81812962 |
| 99 | response to parathyroid hormone (GO:0071107) | 2.81499760 |
| 100 | membrane repolarization (GO:0086009) | 2.80741001 |
| 101 | phosphate ion transport (GO:0006817) | 2.80730742 |
| 102 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.79567964 |
| 103 | drug transmembrane transport (GO:0006855) | 2.79389460 |
| 104 | glyoxylate metabolic process (GO:0046487) | 2.79386289 |
| 105 | sodium ion homeostasis (GO:0055078) | 2.79307003 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 2.79239181 |
| 107 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.78372554 |
| 108 | positive regulation of membrane potential (GO:0045838) | 2.77973374 |
| 109 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.77796243 |
| 110 | activation of protein kinase A activity (GO:0034199) | 2.77634685 |
| 111 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.76646879 |
| 112 | dopamine receptor signaling pathway (GO:0007212) | 2.76616575 |
| 113 | monocarboxylic acid catabolic process (GO:0072329) | 2.76467762 |
| 114 | positive regulation of lipid catabolic process (GO:0050996) | 2.75078606 |
| 115 | regulation of synaptic plasticity (GO:0048167) | 2.73565380 |
| 116 | ethanol oxidation (GO:0006069) | 2.72594308 |
| 117 | postsynaptic membrane organization (GO:0001941) | 2.70891224 |
| 118 | L-phenylalanine metabolic process (GO:0006558) | 2.70648345 |
| 119 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.70648345 |
| 120 | cysteine metabolic process (GO:0006534) | 2.70024711 |
| 121 | phosphate ion transmembrane transport (GO:0035435) | 2.69454313 |
| 122 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.68669047 |
| 123 | oxaloacetate metabolic process (GO:0006107) | 2.68599061 |
| 124 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.67614965 |
| 125 | desmosome organization (GO:0002934) | 2.66794477 |
| 126 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.66566471 |
| 127 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.66558885 |
| 128 | regulation of cell communication by electrical coupling (GO:0010649) | 2.66235678 |
| 129 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.64410063 |
| 130 | intracellular lipid transport (GO:0032365) | 2.64190438 |
| 131 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.64033438 |
| 132 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.63342229 |
| 133 | regulation of female receptivity (GO:0045924) | 2.62667835 |
| 134 | branched-chain amino acid metabolic process (GO:0009081) | 2.61830320 |
| 135 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.60927270 |
| 136 | protein localization to synapse (GO:0035418) | 2.60785709 |
| 137 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.60534718 |
| 138 | branched-chain amino acid catabolic process (GO:0009083) | 2.60497917 |
| 139 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60195242 |
| 140 | L-phenylalanine catabolic process (GO:0006559) | 2.60195242 |
| 141 | neurotransmitter secretion (GO:0007269) | 2.60096913 |
| 142 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.59739639 |
| 143 | synaptic transmission, glutamatergic (GO:0035249) | 2.59139717 |
| 144 | layer formation in cerebral cortex (GO:0021819) | 2.58190658 |
| 145 | serine family amino acid catabolic process (GO:0009071) | 2.56772327 |
| 146 | myelin maintenance (GO:0043217) | 2.55940131 |
| 147 | dicarboxylic acid catabolic process (GO:0043649) | 2.54574551 |
| 148 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.53933134 |
| 149 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53228579 |
| 150 | response to mercury ion (GO:0046689) | 2.52928282 |
| 151 | regulation of neurotransmitter secretion (GO:0046928) | 2.52625220 |
| 152 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.52066238 |
| 153 | cerebellar Purkinje cell layer development (GO:0021680) | 2.51366942 |
| 154 | auditory behavior (GO:0031223) | 2.49073773 |
| 155 | detection of calcium ion (GO:0005513) | 2.48911061 |
| 156 | negative regulation of inclusion body assembly (GO:0090084) | 2.48852745 |
| 157 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.48700174 |
| 158 | neurotransmitter catabolic process (GO:0042135) | 2.47399057 |
| 159 | positive regulation of sodium ion transport (GO:0010765) | 2.47120819 |
| 160 | motile cilium assembly (GO:0044458) | 2.46301462 |
| 161 | regulation of vesicle fusion (GO:0031338) | 2.46051132 |
| 162 | membrane depolarization during action potential (GO:0086010) | 2.45316127 |
| 163 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.43888834 |
| 164 | gamma-aminobutyric acid transport (GO:0015812) | 2.42561619 |
| 165 | dendritic spine morphogenesis (GO:0060997) | 2.42448007 |
| 166 | ethanol metabolic process (GO:0006067) | 2.42181628 |
| 167 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.40886376 |
| 168 | mating behavior (GO:0007617) | 2.38174683 |
| 169 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.34872436 |
| 170 | cellular response to monoamine stimulus (GO:0071868) | 2.34851789 |
| 171 | cellular response to catecholamine stimulus (GO:0071870) | 2.34851789 |
| 172 | cGMP-mediated signaling (GO:0019934) | 2.34586158 |
| 173 | long-term memory (GO:0007616) | 2.33678974 |
| 174 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.32543236 |
| 175 | cell migration in hindbrain (GO:0021535) | 2.32205791 |
| 176 | cell-cell junction maintenance (GO:0045217) | 2.31896090 |
| 177 | synaptic vesicle endocytosis (GO:0048488) | 2.31706405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.49879943 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.00646882 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87346087 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.73728191 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48697968 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.47000094 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40268496 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.37304158 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21782188 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06435161 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02979472 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00181315 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97290568 |
| 14 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.88278555 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88186722 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88186722 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.83275830 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82518384 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.81799336 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80481478 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.79592278 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.79209710 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77707967 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75929373 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70231873 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66592212 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62455223 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.60226897 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.59258992 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.58975164 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56446536 |
| 32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.56249304 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51733721 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51270167 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50781867 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48717509 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48454090 |
| 38 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44422862 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.43414750 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42128725 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40990876 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40496418 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38309091 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35271052 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34177096 |
| 46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33530972 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33201241 |
| 48 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32786271 |
| 49 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32718116 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32463196 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31886027 |
| 52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31467723 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31467723 |
| 54 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.28835744 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28459930 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26717069 |
| 57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26320946 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25898654 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23134099 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22651372 |
| 61 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22563353 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19815182 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19155134 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18426577 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18243286 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15880174 |
| 67 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14966499 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13282202 |
| 69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13064968 |
| 70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12135960 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10723095 |
| 72 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.10605256 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10093827 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08434948 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07766142 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07397238 |
| 77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07394777 |
| 78 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.06542462 |
| 79 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.05527431 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05526162 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04938354 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04900997 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03348208 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02937932 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02558779 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02452252 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02028365 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01098982 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.01078386 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00981052 |
| 91 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99077923 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98357907 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98327808 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97286688 |
| 95 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96409243 |
| 96 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95901871 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95102195 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95028293 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93461051 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93427093 |
| 101 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93280146 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92566437 |
| 103 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90451845 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90161017 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89808732 |
| 106 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87911799 |
| 107 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87906002 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87703790 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87398341 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86964285 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85548556 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84755569 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84449479 |
| 114 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.83554572 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82511116 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82165313 |
| 117 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81596084 |
| 118 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.81487433 |
| 119 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81307420 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80741701 |
| 121 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.80537206 |
| 122 | AR_25329375_ChIP-Seq_VCAP_Human | 0.80524616 |
| 123 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79306650 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78390023 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78229443 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77603328 |
| 127 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.76931413 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.75919072 |
| 129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75467905 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74904395 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74902282 |
| 132 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.74492687 |
| 133 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73929499 |
| 134 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73762824 |
| 135 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.73422108 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73275664 |
| 137 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.71986910 |
| 138 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.71445880 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.71334529 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70813851 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69970204 |
| 142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69970204 |
| 143 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.69705831 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69589027 |
| 145 | AR_19668381_ChIP-Seq_PC3_Human | 0.68849672 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68444122 |
| 147 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.68159571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 3.99766405 |
| 2 | MP0003646_muscle_fatigue | 3.81312247 |
| 3 | MP0003880_abnormal_central_pattern | 3.67487223 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.57263202 |
| 5 | MP0005360_urolithiasis | 3.46014985 |
| 6 | MP0002822_catalepsy | 3.41369894 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.33174433 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.04604481 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.97103644 |
| 10 | MP0004130_abnormal_muscle_cell | 2.88684239 |
| 11 | MP0003195_calcinosis | 2.86792316 |
| 12 | MP0000751_myopathy | 2.84498365 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.79016758 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.70130359 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.67717169 |
| 16 | MP0003329_amyloid_beta_deposits | 2.51248330 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.40557881 |
| 18 | MP0005365_abnormal_bile_salt | 2.33828725 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.30965288 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.22381125 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 2.19470995 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.15530641 |
| 23 | MP0005330_cardiomyopathy | 2.10531242 |
| 24 | MP0005332_abnormal_amino_acid | 2.10202455 |
| 25 | MP0004036_abnormal_muscle_relaxation | 2.05490020 |
| 26 | MP0003252_abnormal_bile_duct | 2.03921619 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98420189 |
| 28 | MP0005535_abnormal_body_temperature | 1.88354275 |
| 29 | MP0004484_altered_response_of | 1.86022814 |
| 30 | MP0003123_paternal_imprinting | 1.82846154 |
| 31 | MP0008775_abnormal_heart_ventricle | 1.79721223 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.79621119 |
| 33 | MP0001970_abnormal_pain_threshold | 1.78600791 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.75377116 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.73507079 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.72142974 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.69626405 |
| 38 | MP0009046_muscle_twitch | 1.68818223 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.67959860 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.67905312 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.66786872 |
| 42 | MP0005670_abnormal_white_adipose | 1.66501157 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.65441852 |
| 44 | MP0005409_darkened_coat_color | 1.63036727 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.61873711 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.60009031 |
| 47 | MP0000749_muscle_degeneration | 1.59087034 |
| 48 | MP0000566_synostosis | 1.58817751 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.58474637 |
| 50 | MP0001765_abnormal_ion_homeostasis | 1.57636194 |
| 51 | MP0002972_abnormal_cardiac_muscle | 1.55260933 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.51573083 |
| 53 | MP0002971_abnormal_brown_adipose | 1.51406090 |
| 54 | MP0002735_abnormal_chemical_nociception | 1.48086281 |
| 55 | MP0000920_abnormal_myelination | 1.45957316 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41531051 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.37782591 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.36528148 |
| 59 | MP0009745_abnormal_behavioral_response | 1.33049179 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.32687234 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.31828969 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.31486849 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.31325007 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.31072243 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.28725041 |
| 66 | MP0000747_muscle_weakness | 1.27584601 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.26872902 |
| 68 | MP0001756_abnormal_urination | 1.26422453 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.25456305 |
| 70 | MP0004742_abnormal_vestibular_system | 1.23926911 |
| 71 | MP0005646_abnormal_pituitary_gland | 1.23731939 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.22946514 |
| 73 | MP0002796_impaired_skin_barrier | 1.22730405 |
| 74 | MP0001544_abnormal_cardiovascular_syste | 1.22405479 |
| 75 | MP0005385_cardiovascular_system_phenoty | 1.22405479 |
| 76 | MP0002106_abnormal_muscle_physiology | 1.22315668 |
| 77 | MP0002653_abnormal_ependyma_morphology | 1.20384863 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.18671810 |
| 79 | MP0001485_abnormal_pinna_reflex | 1.17252874 |
| 80 | MP0002063_abnormal_learning/memory/cond | 1.14703696 |
| 81 | MP0000013_abnormal_adipose_tissue | 1.13809457 |
| 82 | MP0003631_nervous_system_phenotype | 1.13307282 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 1.13003664 |
| 84 | MP0005451_abnormal_body_composition | 1.12940556 |
| 85 | MP0005375_adipose_tissue_phenotype | 1.12858210 |
| 86 | MP0004085_abnormal_heartbeat | 1.12690611 |
| 87 | MP0004510_myositis | 1.12428826 |
| 88 | MP0000230_abnormal_systemic_arterial | 1.11668899 |
| 89 | MP0000604_amyloidosis | 1.10923012 |
| 90 | MP0000955_abnormal_spinal_cord | 1.09952763 |
| 91 | MP0002269_muscular_atrophy | 1.09375320 |
| 92 | MP0002882_abnormal_neuron_morphology | 1.09239497 |
| 93 | MP0004811_abnormal_neuron_physiology | 1.08569660 |
| 94 | MP0008569_lethality_at_weaning | 1.08429244 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 1.08179368 |
| 96 | MP0006138_congestive_heart_failure | 1.08149390 |
| 97 | MP0003075_altered_response_to | 1.07249638 |
| 98 | MP0002064_seizures | 1.06807429 |
| 99 | MP0004270_analgesia | 1.06270529 |
| 100 | MP0001666_abnormal_nutrient_absorption | 1.05191018 |
| 101 | MP0003634_abnormal_glial_cell | 1.04830049 |
| 102 | MP0002736_abnormal_nociception_after | 1.04301164 |
| 103 | MP0003879_abnormal_hair_cell | 1.04084490 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 1.03400636 |
| 105 | MP0001346_abnormal_lacrimal_gland | 1.03393781 |
| 106 | MP0001905_abnormal_dopamine_level | 1.02767468 |
| 107 | MP0005083_abnormal_biliary_tract | 1.01433490 |
| 108 | MP0005369_muscle_phenotype | 1.00769114 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 1.00503919 |
| 110 | MP0003787_abnormal_imprinting | 1.00460427 |
| 111 | MP0005187_abnormal_penis_morphology | 0.98882777 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.97808958 |
| 113 | MP0001486_abnormal_startle_reflex | 0.95221264 |
| 114 | MP0006276_abnormal_autonomic_nervous | 0.94712813 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.94614070 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.94012913 |
| 117 | MP0010630_abnormal_cardiac_muscle | 0.93566787 |
| 118 | MP0000778_abnormal_nervous_system | 0.93420322 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.90972074 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.90795156 |
| 121 | MP0002229_neurodegeneration | 0.88149538 |
| 122 | MP0003122_maternal_imprinting | 0.87972365 |
| 123 | MP0004885_abnormal_endolymph | 0.86673634 |
| 124 | MP0002272_abnormal_nervous_system | 0.86623301 |
| 125 | MP0003633_abnormal_nervous_system | 0.86154959 |
| 126 | MP0005165_increased_susceptibility_to | 0.85541686 |
| 127 | MP0000609_abnormal_liver_physiology | 0.84416640 |
| 128 | MP0008872_abnormal_physiological_respon | 0.83779703 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.83707148 |
| 130 | MP0005377_hearing/vestibular/ear_phenot | 0.81846473 |
| 131 | MP0003878_abnormal_ear_physiology | 0.81846473 |
| 132 | MP0003191_abnormal_cellular_cholesterol | 0.81059428 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.80220716 |
| 134 | MP0008874_decreased_physiological_sensi | 0.79973358 |
| 135 | MP0002152_abnormal_brain_morphology | 0.79917174 |
| 136 | MP0003690_abnormal_glial_cell | 0.79556430 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.79291326 |
| 138 | MP0001440_abnormal_grooming_behavior | 0.78768407 |
| 139 | MP0001984_abnormal_olfaction | 0.78381891 |
| 140 | MP0003632_abnormal_nervous_system | 0.78120727 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75350432 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.75128618 |
| 143 | MP0000026_abnormal_inner_ear | 0.73935668 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.73099954 |
| 145 | MP0005386_behavior/neurological_phenoty | 0.72916821 |
| 146 | MP0004924_abnormal_behavior | 0.72916821 |
| 147 | MP0003938_abnormal_ear_development | 0.71381484 |
| 148 | MP0005448_abnormal_energy_balance | 0.71271932 |
| 149 | MP0005166_decreased_susceptibility_to | 0.70349968 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.68232037 |
| 151 | MP0002876_abnormal_thyroid_physiology | 0.67663339 |
| 152 | MP0005503_abnormal_tendon_morphology | 0.64396334 |
| 153 | MP0002184_abnormal_innervation | 0.63155420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.33831934 |
| 2 | Obstructive sleep apnea (HP:0002870) | 4.32517191 |
| 3 | Hyperglycinuria (HP:0003108) | 4.27464178 |
| 4 | Gout (HP:0001997) | 4.22947693 |
| 5 | Ventricular fibrillation (HP:0001663) | 4.22613117 |
| 6 | Bundle branch block (HP:0011710) | 4.21046206 |
| 7 | Myoglobinuria (HP:0002913) | 4.13873105 |
| 8 | Abnormality of binocular vision (HP:0011514) | 4.08700098 |
| 9 | Diplopia (HP:0000651) | 4.08700098 |
| 10 | Neurofibrillary tangles (HP:0002185) | 3.88759994 |
| 11 | Sudden death (HP:0001699) | 3.81907710 |
| 12 | Increased circulating renin level (HP:0000848) | 3.81226772 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.78063226 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.72954865 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.68937996 |
| 16 | Ketoacidosis (HP:0001993) | 3.68713596 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.61987150 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.56907876 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.56907876 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.53609617 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.52668595 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.52668595 |
| 23 | Ankle clonus (HP:0011448) | 3.50230935 |
| 24 | Ketosis (HP:0001946) | 3.48417334 |
| 25 | Myokymia (HP:0002411) | 3.46809610 |
| 26 | Hypokalemic alkalosis (HP:0001949) | 3.44569382 |
| 27 | Abnormal ciliary motility (HP:0012262) | 3.42577209 |
| 28 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.40789971 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.37023028 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.37023028 |
| 31 | Metabolic alkalosis (HP:0200114) | 3.35856621 |
| 32 | Hyperglycinemia (HP:0002154) | 3.31416119 |
| 33 | Heart block (HP:0012722) | 3.29115481 |
| 34 | Febrile seizures (HP:0002373) | 3.22843875 |
| 35 | Hyperammonemia (HP:0001987) | 3.21392997 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18731422 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 3.17005694 |
| 38 | Focal motor seizures (HP:0011153) | 3.09190736 |
| 39 | Hyperuricemia (HP:0002149) | 3.05457559 |
| 40 | Increased purine levels (HP:0004368) | 3.05457559 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 3.05359247 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 3.04412755 |
| 43 | Calf muscle hypertrophy (HP:0008981) | 3.03088722 |
| 44 | Abnormal eating behavior (HP:0100738) | 3.02723696 |
| 45 | Atrioventricular block (HP:0001678) | 3.00445114 |
| 46 | Atonic seizures (HP:0010819) | 3.00409888 |
| 47 | Ventricular tachycardia (HP:0004756) | 3.00144138 |
| 48 | Syncope (HP:0001279) | 2.90101804 |
| 49 | Atrial fibrillation (HP:0005110) | 2.89522445 |
| 50 | Hyperactive renin-angiotensin system (HP:0000841) | 2.84878054 |
| 51 | Papilledema (HP:0001085) | 2.84755417 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.81431579 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.81431579 |
| 54 | Annular pancreas (HP:0001734) | 2.79677007 |
| 55 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.79583492 |
| 56 | Ventricular arrhythmia (HP:0004308) | 2.77009100 |
| 57 | Torticollis (HP:0000473) | 2.77002253 |
| 58 | Abnormality of chloride homeostasis (HP:0011422) | 2.75594943 |
| 59 | Xanthomatosis (HP:0000991) | 2.72185921 |
| 60 | Primary atrial arrhythmia (HP:0001692) | 2.70527706 |
| 61 | Muscle fiber splitting (HP:0003555) | 2.69247237 |
| 62 | Sleep apnea (HP:0010535) | 2.68054760 |
| 63 | Rhabdomyolysis (HP:0003201) | 2.67365644 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.65082916 |
| 65 | Hyporeflexia of lower limbs (HP:0002600) | 2.65020835 |
| 66 | Rhinitis (HP:0012384) | 2.64308106 |
| 67 | Prolonged QT interval (HP:0001657) | 2.63291802 |
| 68 | Nasal polyposis (HP:0100582) | 2.61173292 |
| 69 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.57649714 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.55743628 |
| 71 | Hyperaldosteronism (HP:0000859) | 2.54868649 |
| 72 | Absence seizures (HP:0002121) | 2.53882438 |
| 73 | Difficulty running (HP:0009046) | 2.53642782 |
| 74 | Abnormality of renin-angiotensin system (HP:0000847) | 2.53230729 |
| 75 | Postural instability (HP:0002172) | 2.52938320 |
| 76 | Supraventricular tachycardia (HP:0004755) | 2.52874416 |
| 77 | Peripheral hypomyelination (HP:0007182) | 2.49159257 |
| 78 | Foot dorsiflexor weakness (HP:0009027) | 2.47643778 |
| 79 | Action tremor (HP:0002345) | 2.46763572 |
| 80 | Supraventricular arrhythmia (HP:0005115) | 2.45168639 |
| 81 | Proximal tubulopathy (HP:0000114) | 2.44201533 |
| 82 | Palpitations (HP:0001962) | 2.43834519 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.43508501 |
| 84 | Neonatal onset (HP:0003623) | 2.42817959 |
| 85 | Alkalosis (HP:0001948) | 2.41781007 |
| 86 | Muscle stiffness (HP:0003552) | 2.39612988 |
| 87 | Limb dystonia (HP:0002451) | 2.37752278 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.36574552 |
| 89 | Focal dystonia (HP:0004373) | 2.36188265 |
| 90 | Renal salt wasting (HP:0000127) | 2.34795890 |
| 91 | Abnormality of the calf musculature (HP:0001430) | 2.34240076 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 2.33215998 |
| 93 | Hypercortisolism (HP:0001578) | 2.31912697 |
| 94 | Hypomagnesemia (HP:0002917) | 2.31056192 |
| 95 | Asymmetric septal hypertrophy (HP:0001670) | 2.30046441 |
| 96 | Polyuria (HP:0000103) | 2.29889270 |
| 97 | Abnormal urine output (HP:0012590) | 2.27887655 |
| 98 | Metabolic acidosis (HP:0001942) | 2.26968584 |
| 99 | Chronic bronchitis (HP:0004469) | 2.26946938 |
| 100 | Dysmetric saccades (HP:0000641) | 2.26791735 |
| 101 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26485651 |
| 102 | Depression (HP:0000716) | 2.25458688 |
| 103 | Abnormal EKG (HP:0003115) | 2.24784734 |
| 104 | Cerebral edema (HP:0002181) | 2.23733483 |
| 105 | Craniofacial dystonia (HP:0012179) | 2.23372117 |
| 106 | Bronchomalacia (HP:0002780) | 2.23261320 |
| 107 | Akinesia (HP:0002304) | 2.20421024 |
| 108 | Distal lower limb muscle weakness (HP:0009053) | 2.19296352 |
| 109 | Hypoalphalipoproteinemia (HP:0003233) | 2.18351195 |
| 110 | Abnormality of serum amino acid levels (HP:0003112) | 2.18284638 |
| 111 | Conjunctival hamartoma (HP:0100780) | 2.17487761 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 2.17384958 |
| 113 | Hyperkalemia (HP:0002153) | 2.15342904 |
| 114 | Truncus arteriosus (HP:0001660) | 2.15156132 |
| 115 | Status epilepticus (HP:0002133) | 2.13492893 |
| 116 | Spastic gait (HP:0002064) | 2.13166030 |
| 117 | Dysmetria (HP:0001310) | 2.13136105 |
| 118 | Epidermoid cyst (HP:0200040) | 2.13096737 |
| 119 | Abnormality of renal excretion (HP:0011036) | 2.12900996 |
| 120 | Progressive cerebellar ataxia (HP:0002073) | 2.11721968 |
| 121 | Lethargy (HP:0001254) | 2.11703977 |
| 122 | Nausea (HP:0002018) | 2.11692122 |
| 123 | Rigidity (HP:0002063) | 2.10970506 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 2.10828045 |
| 125 | Abnormality of complement system (HP:0005339) | 2.10752516 |
| 126 | Abnormality of potassium homeostasis (HP:0011042) | 2.10163004 |
| 127 | Atelectasis (HP:0100750) | 2.09413792 |
| 128 | Visual hallucinations (HP:0002367) | 2.09251407 |
| 129 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08726428 |
| 130 | Adrenal overactivity (HP:0002717) | 2.04846492 |
| 131 | Hyperthyroidism (HP:0000836) | 2.03657345 |
| 132 | Hyperparathyroidism (HP:0000843) | 2.03230908 |
| 133 | Dialeptic seizures (HP:0011146) | 2.03029995 |
| 134 | Central scotoma (HP:0000603) | 2.02356241 |
| 135 | Deep venous thrombosis (HP:0002625) | 2.00078387 |
| 136 | Hypokalemia (HP:0002900) | 1.99680275 |
| 137 | Vomiting (HP:0002013) | 1.97772474 |
| 138 | Generalized tonic-clonic seizures (HP:0002069) | 1.97751337 |
| 139 | Dysdiadochokinesis (HP:0002075) | 1.95111248 |
| 140 | Axonal loss (HP:0003447) | 1.94817804 |
| 141 | Hemiplegia (HP:0002301) | 1.93751777 |
| 142 | Intention tremor (HP:0002080) | 1.93461098 |
| 143 | Neonatal death (HP:0003811) | 1.93441976 |
| 144 | Tetraplegia (HP:0002445) | 1.93269981 |
| 145 | Truncal ataxia (HP:0002078) | 1.92503580 |
| 146 | Anxiety (HP:0000739) | 1.91168026 |
| 147 | Myotonia (HP:0002486) | 1.91158330 |
| 148 | Subaortic stenosis (HP:0001682) | 1.90119653 |
| 149 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.90119653 |
| 150 | Delayed CNS myelination (HP:0002188) | 1.89913256 |
| 151 | Turricephaly (HP:0000262) | 1.89682713 |
| 152 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.89098195 |
| 153 | Lipoatrophy (HP:0100578) | 1.88964603 |
| 154 | Focal seizures (HP:0007359) | 1.88795711 |
| 155 | Dilated cardiomyopathy (HP:0001644) | 1.85585782 |
| 156 | Glomerulonephritis (HP:0000099) | 1.84820663 |
| 157 | Intrahepatic cholestasis (HP:0001406) | 1.84447911 |
| 158 | Complement deficiency (HP:0004431) | 1.84202230 |
| 159 | Growth hormone excess (HP:0000845) | 1.84201723 |
| 160 | Hepatic necrosis (HP:0002605) | 1.84091128 |
| 161 | Rapidly progressive (HP:0003678) | 1.80630987 |
| 162 | Mutism (HP:0002300) | 1.79922541 |
| 163 | Cerebral hypomyelination (HP:0006808) | 1.79114413 |
| 164 | EMG: neuropathic changes (HP:0003445) | 1.79027762 |
| 165 | Stereotypic behavior (HP:0000733) | 1.76846379 |
| 166 | Infertility (HP:0000789) | 1.74330475 |
| 167 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.72608363 |
| 168 | Decreased circulating renin level (HP:0003351) | 1.72031297 |
| 169 | Bradykinesia (HP:0002067) | 1.71722734 |
| 170 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.71563030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 3.18428883 |
| 2 | TRIB3 | 2.98581694 |
| 3 | PDK3 | 2.97846369 |
| 4 | PDK4 | 2.97846369 |
| 5 | MAPK15 | 2.82868251 |
| 6 | EPHA4 | 2.82261395 |
| 7 | NEK1 | 2.80604274 |
| 8 | WNK4 | 2.79193015 |
| 9 | DAPK2 | 2.54421108 |
| 10 | LMTK2 | 2.40250305 |
| 11 | UHMK1 | 2.38709826 |
| 12 | MARK1 | 2.38449655 |
| 13 | STK38 | 2.33014536 |
| 14 | PRPF4B | 2.19295646 |
| 15 | TTN | 2.14138202 |
| 16 | WNK3 | 2.07527669 |
| 17 | BCKDK | 2.06903300 |
| 18 | PRKD3 | 2.03095196 |
| 19 | PHKG1 | 1.99012144 |
| 20 | PHKG2 | 1.99012144 |
| 21 | OXSR1 | 1.98634674 |
| 22 | CAMKK1 | 1.93097063 |
| 23 | MAP3K9 | 1.93057901 |
| 24 | PDK2 | 1.89060853 |
| 25 | KSR2 | 1.88281611 |
| 26 | NTRK3 | 1.87311634 |
| 27 | OBSCN | 1.76580465 |
| 28 | SIK2 | 1.69707950 |
| 29 | PKN2 | 1.62343504 |
| 30 | RIPK4 | 1.59624759 |
| 31 | MAP2K4 | 1.58620164 |
| 32 | MARK2 | 1.55278091 |
| 33 | RIPK1 | 1.43403701 |
| 34 | STK39 | 1.38521984 |
| 35 | ARAF | 1.37533340 |
| 36 | MAP3K11 | 1.32745401 |
| 37 | MST1R | 1.31866531 |
| 38 | PAK6 | 1.30672861 |
| 39 | TAOK1 | 1.27588672 |
| 40 | MAP3K2 | 1.21383538 |
| 41 | SIK1 | 1.17505639 |
| 42 | ICK | 1.16215947 |
| 43 | WNK1 | 1.15085230 |
| 44 | SMG1 | 1.09272003 |
| 45 | MAP3K7 | 1.05889504 |
| 46 | MAP3K4 | 1.03637397 |
| 47 | CAMK2B | 1.02399208 |
| 48 | MINK1 | 0.99891686 |
| 49 | MAP3K13 | 0.99284285 |
| 50 | CAMK1 | 0.98286521 |
| 51 | INSRR | 0.98089041 |
| 52 | CAMKK2 | 0.96340425 |
| 53 | PRKCH | 0.94690624 |
| 54 | PDK1 | 0.91299842 |
| 55 | SGK3 | 0.91119346 |
| 56 | STK24 | 0.90983676 |
| 57 | DMPK | 0.87996478 |
| 58 | ERN1 | 0.86229105 |
| 59 | PDPK1 | 0.85440041 |
| 60 | CAMK2G | 0.83015451 |
| 61 | PRKAA2 | 0.82533862 |
| 62 | SGK2 | 0.81606685 |
| 63 | SGK494 | 0.80560410 |
| 64 | SGK223 | 0.80560410 |
| 65 | MAP2K7 | 0.79962168 |
| 66 | PRKAA1 | 0.79369551 |
| 67 | FRK | 0.78843007 |
| 68 | MAP3K1 | 0.78037871 |
| 69 | MUSK | 0.77699877 |
| 70 | TESK1 | 0.77616737 |
| 71 | DYRK1A | 0.75807933 |
| 72 | STK11 | 0.75544040 |
| 73 | TIE1 | 0.75525506 |
| 74 | TNK2 | 0.73636600 |
| 75 | CDK15 | 0.73059846 |
| 76 | ALK | 0.72224150 |
| 77 | CDK11A | 0.71205220 |
| 78 | MAPK10 | 0.71031207 |
| 79 | PTK6 | 0.70733026 |
| 80 | LRRK2 | 0.69927392 |
| 81 | JAK2 | 0.69811466 |
| 82 | PIK3CG | 0.66508662 |
| 83 | PRKD1 | 0.66012235 |
| 84 | CDK5 | 0.65655187 |
| 85 | CAMK4 | 0.65241908 |
| 86 | PKN1 | 0.64095368 |
| 87 | RET | 0.63830826 |
| 88 | GRK5 | 0.62643330 |
| 89 | SGK1 | 0.62411783 |
| 90 | CDK14 | 0.62350980 |
| 91 | HIPK2 | 0.61596550 |
| 92 | PAK3 | 0.61513823 |
| 93 | CDK18 | 0.61440296 |
| 94 | CAMK1D | 0.60455379 |
| 95 | MAPKAPK5 | 0.59670027 |
| 96 | PRKCG | 0.59191630 |
| 97 | NTRK1 | 0.58851119 |
| 98 | NEK6 | 0.58683463 |
| 99 | CAMK2D | 0.57935563 |
| 100 | PNCK | 0.57864467 |
| 101 | PRKACG | 0.57301163 |
| 102 | CAMK2A | 0.56987173 |
| 103 | FER | 0.56486749 |
| 104 | MAPK4 | 0.56409699 |
| 105 | JAK1 | 0.56265358 |
| 106 | STK38L | 0.55758144 |
| 107 | PRKG2 | 0.55511527 |
| 108 | MAP2K2 | 0.54497264 |
| 109 | PIK3CA | 0.54210987 |
| 110 | PRKCZ | 0.53512685 |
| 111 | MAPK12 | 0.52786026 |
| 112 | MAP2K6 | 0.52502396 |
| 113 | ERBB2 | 0.51670200 |
| 114 | MAP2K3 | 0.51108071 |
| 115 | CDK19 | 0.49808871 |
| 116 | TYRO3 | 0.49536836 |
| 117 | EEF2K | 0.48017768 |
| 118 | CDC42BPA | 0.47568225 |
| 119 | FGFR4 | 0.46597092 |
| 120 | MAP2K1 | 0.45689643 |
| 121 | RPS6KA3 | 0.45572783 |
| 122 | NTRK2 | 0.45561913 |
| 123 | DYRK1B | 0.44677340 |
| 124 | BRAF | 0.44647068 |
| 125 | MAP3K3 | 0.43874689 |
| 126 | TAOK2 | 0.43163436 |
| 127 | MAPK7 | 0.43006248 |
| 128 | BMX | 0.41595455 |
| 129 | CASK | 0.41407640 |
| 130 | DAPK3 | 0.40935648 |
| 131 | MAPKAPK3 | 0.40631268 |
| 132 | MAPK11 | 0.40322315 |
| 133 | MAPK13 | 0.40184122 |
| 134 | DAPK1 | 0.39626914 |
| 135 | LATS2 | 0.38334245 |
| 136 | PRKACA | 0.38008134 |
| 137 | ABL2 | 0.35632503 |
| 138 | CAMK1G | 0.35559777 |
| 139 | PDGFRA | 0.33827488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48931967 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.23254512 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08598914 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.06962052 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68438132 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.60980004 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38437303 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.29738839 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16412369 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15169334 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07561066 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06300145 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80156589 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78808173 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67009181 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62793208 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51590527 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.51429890 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.50788693 |
| 20 | Prion diseases_Homo sapiens_hsa05020 | 1.43447479 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.42917980 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42590812 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37710555 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.37411937 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24652172 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17540899 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.15710404 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.12665844 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09486185 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08834990 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06403458 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05303365 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04140782 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01894831 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00184894 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 0.95727302 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95367711 |
| 38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94726088 |
| 39 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94297577 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93990207 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93930060 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93778656 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92417155 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90234171 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 0.90014787 |
| 46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89910237 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89872969 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88228702 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.87550219 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 0.86611050 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86494220 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86124680 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86071411 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85402528 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.85184414 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.84529147 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.83477463 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82682520 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82093891 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80938256 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80590459 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.79888738 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79722919 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77553104 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.76102223 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75786076 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75080425 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74713761 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.72044876 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71908301 |
| 71 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70869666 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70209401 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70063263 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69598097 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69150050 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68649174 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.68507629 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68153658 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.67320374 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67184397 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66738971 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.64001511 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63305268 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63167264 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62697785 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62156584 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61484444 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60858202 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60724655 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60616045 |
| 91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58761928 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58020529 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57091145 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55056267 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54833989 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54823495 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.54091800 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52163933 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.50463673 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50145580 |
| 101 | Taste transduction_Homo sapiens_hsa04742 | 0.49499782 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49277098 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47984158 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47961668 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47883637 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47668016 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47502242 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47156618 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46754595 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45761689 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45416644 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44344775 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43504737 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42393509 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41442837 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40358488 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39666250 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39148678 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39051061 |
| 120 | Axon guidance_Homo sapiens_hsa04360 | 0.38937412 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38711155 |
| 122 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37897999 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37728319 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37173331 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.36985004 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34565209 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34385645 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33474726 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33373536 |
| 130 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33148268 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32495230 |
| 132 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31540395 |

